Aslan Pharmaceuticals: A Small Firm with Early, Promising Results for Atopic Dermatitis

Aslan Pharmaceuticals 
Aslan Pharmaceuticals (ASLN) is a clinical-stage immunology company announced positive interim unblinded data from three dose cohorts of its ongoing randomized, double-blind placebo-controlled multiple ascending dose study of ASLAN-004 for moderate to severe atopic dermatitis.  

ASLAN004 was well tolerated across all doses. It demonstrated improvements compared . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.